Early treatment of intracanalicular vestibular schwannomas (IVSs) may be advisable because their spontaneous course will show hearing loss in most cases. Advanced microsurgical techniques and continuous intraoperative monitoring of cranial nerves may allow hearing preservation (HP) without facial nerve damage. However, there are still controversies about the definition of HP and the best surgical approach that should be used. In this study, we reviewed the main data from the recent literature on IVS surgery and compared hearing, facial function and complication rates after the retrosigmoid and middle fossa approaches, respectively. The results showed that the average HP rate is approximately 45% after IVS surgery whatever the surgical route. HP varied widely depending on the audiometric criteria that were used for definition of serviceable hearing. There was a trend to show that middle fossa approach offered a better quality of postoperative hearing (not statistically significant), whereas the retrosigmoid approach offered a better facial nerve preservation and fewer complications (not statistically significant). We believe that the timing of treatment in the course of the disease and selection between radiosurgical versus microsurgical procedure are key issues in the management of IVS. Once open surgery has been decided, selection of the approach mainly depends on individual anatomical considerations and experience of the surgeon.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000156916 | DOI Listing |
Cureus
November 2024
Oculoplastic, Orbital & Lacrimal Surgery, Aichi Medical University Hospital, Aichi, JPN.
Canaliculops is a rare case of a medial canthal mass due to a non-infectious dilation of the canaliculus and easily mimics canaliculitis with canalicular dilation. We report a case of a 68-year-old woman with a five-year history of progressive swelling of the right upper eyelid. The patient was previously diagnosed with canaliculitis at other clinics and had a history of diabetes mellitus.
View Article and Find Full Text PDFClin Ophthalmol
September 2024
Ocular Therapeutix, Inc., Bedford, MA, USA.
Clin Ophthalmol
September 2024
Department of Ophthalmology, King Salman Bin Abdulaziz Medical City, Madinah, Saudi Arabia.
Am J Ophthalmol
December 2024
Kellogg Eye Center and Department of Ophthalmology and Visual Sciences (J.N.S., H.L., C.T.H., S.I.M.), University of Michigan, Ann Arbor, Michigan, USA. Electronic address:
Purpose: To compare the efficacy of an intracanalicular dexamethasone intracanalicular insert (DII) to a topical prednisolone acetate 1% taper for preventing breakthrough inflammation (iritis or cystoid macular edema [CME]) during the first postoperative month (POM1) after cataract surgery.
Design: Retrospective, nonrandomized comparative interventional study.
Methods: Patients received either DII or topical prednisolone acetate 1% eyedrops (control) during POM1.
Clin Ophthalmol
July 2024
Advanced Vision Care, Los Angeles, CA, USA.
Purpose: To assess the efficiency and safety of an intracanalicular dexamethasone insert (Dextenza, Ocular Therapeutix, Inc) supplemented with a reduced-frequency topical drop regimen in mitigating pain and inflammation post-penetrating keratoplasty (PKP), Descemet stripping endothelial keratoplasty (DSEK), and Descemet membrane endothelial keratoplasty (DMEK), compared to standard topical corticosteroid therapy.
Patients And Methods: Eyes were categorized within the DSEK, DMEK, or PKP groups based on ocular characteristics and surgical indications. Randomized in a 1:1 ratio, the intervention group received Dextenza alongside a lowered drop frequency, while the control group followed a conventional drop protocol with no Dextenza.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!